Symbiotec Pharmalab Ltd IPO
MainboardPrice Band
₹938-988
Issue Size
₹1757 Cr
Lot Size
15
Open Date
24 Aug 2026
Close Date
27 Aug 2026
Listing Date
1 Sept 2026
This IPO is Closed
Symbiotec Pharmalab Ltd IPO Timeline
Track key IPO dates — from opening and closing to allotment, refund, and listing.
IPO Open Date
24 Aug 2026
IPO Close Date
27 Aug 2026
Allotment Date
28 Aug 2026
Refund Date
28 Aug 2026
Credit to Demat
31 Aug 2026
Listing Date
1 Sept 2026
Symbiotec Pharmalab Ltd IPO Subscription Status
See how the issue is being subscribed across QIB, NII, Retail, and Employee categories.
| Date | QIB | NII | RII | Employee | Total |
|---|---|---|---|---|---|
| 24 Aug 2026 | 0.35x | 1.04x | 0.95x | 1.56x | 0.80x |
| 25 Aug 2026 | 0.54x | 3.00x | 2.10x | 3.01x | 1.85x |
| 26 Aug 2026 | 0.59x | 12.18x | 5.05x | 5.86x | 5.31x |
| 27 Aug 2026 | 172.03x | 73.63x | 12.96x | 15.41x | 71.26x |
Symbiotec Pharmalab Ltd IPO Financials
A quick look at revenue, EBITDA, profit, and net worth over the last three years.
| Year | Total Revenue (Cr) | EBITDA (Cr) | PAT (Cr) | Networth (Cr) | EPS (₹) |
|---|---|---|---|---|---|
| FY25-03 | 788.69 | 250.23 | 145.83 | 910.79 | 133.35 |
| FY24-03 | 693.37 | 162.03 | 88.94 | 761.14 | 81.33 |
| FY23-03 | 575.96 | 27.26 | -22.66 | 672.81 | -20.72 |
Symbiotec Pharmalab Ltd IPO Strengths
- Global leadership in corticosteroid and steroidal hormone APIs.
- Long-standing relationships with domestic and global customer base.
- Fully-invested, multi-scale, vertically integrated manufacturing platform with sustainable practices and clean regulatory track record.
- Continuous investment in R&D, with leading technological capabilities among Indian peers.
- Ability to leverage science and existing competencies to increase total addressable market and deepen intellectual property-driven offerings.
Symbiotec Pharmalab Ltd IPO Reservation
See what share of the issue is reserved for Retail, QIB, NII, and Anchor investors.
| Category | Shares Offered | % of Total |
|---|---|---|
| Retail | 62,13,562 | 34.93% |
| QIB | 35,50,608 | 19.96% |
| NII / HNI | 26,62,955 | 14.97% |
| Anchor Investors | 53,25,910 | 29.94% |
| Employees | 33,407 | 0.19% |
| Total | 1,77,86,442 | 100% |
Symbiotec Pharmalab Ltd Registrar & Company Details
Registrar
MUFG Intime India Pvt Ltd
C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083
+91 810 811 4949
symbiotecpharmalab.ipo@in.mpms.mufg.com
https://in.mpms.mufg.com
Company
Symbiotec Pharmalab Ltd
385/2 Pigdamber Near, Mashal Hotel Rau, Indore, 453331
+91-731-6676405
secretarial@symbiotec.com
CIN: U24232MP2002PLC015293
http://www.symbiotec.com
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
The Symbiotec Pharmalab Ltd IPO has an issue size of ₹1757 crore.
The minimum investment required for the Symbiotec Pharmalab Ltd IPO is ₹14,820, based on a minimum lot size of 15 shares and the applicable IPO price.
The lot size for the Symbiotec Pharmalab Ltd IPO is 15 shares.
The allotment for the Symbiotec Pharmalab Ltd IPO is scheduled for 28 Aug 2026.
Investors can check the Symbiotec Pharmalab Ltd IPO allotment status using their PAN, application number, or other required details through the IPO registrar's website or the relevant stock exchange website.
The registrar for the Symbiotec Pharmalab Ltd IPO is MUFG Intime India Pvt Ltd.
The Symbiotec Pharmalab Ltd IPO opens on 24 Aug 2026 and closes on 27 Aug 2026.
You can apply for the IPO through Anand Rathi using the applicable IPO application process:
Note: Investors are requested to do their own due diligence before investing in any IPO.
The Symbiotec Pharmalab Ltd IPO is scheduled to be listed on 1 Sept 2026 on BSE,NSE.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
